The markets were hit again by a wave of frustration caused by fiddling around the production and testing of COVID-19 vaccines. But on this background, the shares of the pharmaceutical companies Gilead and Moderna received good support, and the capitalization of the companies significantly increased in the moment, which, incidentally, cannot guarantee their further growth. […]